Orthobiologics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 According to a new market study released by Transparency Market Research (TMR), the global orthobiologics market will rise at a 5.90% CAGR from 2013 to 2019. Rising at this robust CAGR, the market’s valuation of US$3.7 bn in 2012 will increase to US$5.5 bn by 2019. The report is titled “Orthobiologics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019” and is available for sale on the company website. In the treatment of osteoarthritis and bone injuries, autografts and allografts have their own limitations, which is why the field of orthobiologics is expected to come to the fore in the coming years, says the report. Orthobiologics aid in expediting tissue and skeletal healing. In recent years, the increasing number of procedures carried out for musculoskeletal problems is the major factor driving the global orthobiologics market. However, lack of transparent reimbursement policies and regulatory mandates for the treatment are detrimental to the market’s growth. Browse Full Research Report: https://www.transparencymarketresearch.com/orthobiologics-market.html The report divides the global orthobiologics market on the basis of product, application, and geography. Bone morphogenetic proteins (BMPs), synthetic bone substitutes, allografts, machined bones, demineralized bone matrix (DBM), viscosupplementation, and stem-cell-based products are the product segments of this market. Amongst all, currently, the viscosupplementation product segment accounts for the largest share of the orthobiologics market due to the high demand for knee treatment surgeries. The higher efficacy of viscosupplementation products over NSAIDs (non-steroidal antiinflammatory drugs) is the reason for this.
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.